Yang Yi, Hansen Lena
Chemical Development, Global Pharmaceutical R&D, Ferring Pharmaceuticals A/S, Amager Strandvej 405, DK-2770 Kastrup, Denmark.
ACS Omega. 2022 Mar 29;7(14):12015-12020. doi: 10.1021/acsomega.2c00214. eCollection 2022 Apr 12.
DKP (diketopiperazine) formation is a ubiquitous side reaction in SPPS (solid-phase peptide synthesis) that is highly sequence-dependent. Secondary amino acids are extremely prone to host such a side reaction. DKP formation is predominantly induced at the Fmoc (fluorenylmethyloxycarbonyl)-removal step mediated by a secondary amine, which conventionally employs piperidine/DMF (dimethylformamide). In this study, alternative Fmoc-removal solution 2% DBU (1,8-diazabicyclo[5.4.0]undec-7-ene)/5% piperazine/NMP (-methyl-2-pyrrolidone) led to drastic DKP reduction relative to 20% piperidine/DMF.
DKP(二酮哌嗪)的形成是固相肽合成(SPPS)中一种普遍存在的副反应,且高度依赖序列。仲氨基酸极易引发这种副反应。DKP的形成主要在由仲胺介导的Fmoc(芴甲氧羰基)去除步骤中诱导产生,传统上该步骤使用哌啶/二甲基甲酰胺(DMF)。在本研究中,替代的Fmoc去除溶液2% 1,8 - 二氮杂双环[5.4.0]十一碳 - 7 - 烯(DBU)/5%哌嗪/ N - 甲基 - 2 - 吡咯烷酮(NMP)与20%哌啶/DMF相比,显著减少了DKP的生成。